Important Announcement – Hemophilia Ontario Name Change
Following a successful vote by our Board of Directors, the motion to change our name from Hemophilia Ontario to Bleeding Disorders Ontario was brought to our community at our recent […]
Hemophilia
2026 John Plater Scholarship Now Accepting Applications!
We are no longer accepting applications for 2026, please check back in 2027. Hemophilia Ontario’s John Plater Scholarship and Bursary Program is now open for 2026 applications. This program honours […]
New Monthly Treatment for Von Willebrand Disease Shows Promise
Star Therapeutics has announced encouraging progress for a potential new treatment for von Willebrand disease (VWD). Their investigational therapy, called VGA039, is designed to be taken just once a month […]
My Make‑A‑Wish Moment with the NBA – Ryan’s Story
Growing up with severe Von Willebrand Type 3, I was constantly treated differently, especially when it came to sports. It was never directly said that I didn’t belong, but it […]
Hemophilia Ontario Stickers
Celebrate World Hemophilia Day with Us! We’ve created a special set of Hemophilia Ontario–themed stickers to mark World Hemophilia Day — featuring our programs, our community, and the spirit of […]
Hemophilia Ontario in the Thunder Bay News!
Nicole Kowal spoke about the impact of Bombardier Blood and the importance of community support. Don’t miss our Thunder Bay screening this Friday — a powerful film and an even […]
Board of Directors Nominations Now Open – Due Before the AGM
Hemophilia Ontario is committed to improving the quality of life for people living with inherited bleeding disorders through advocacy, education, and support. Our Board of Directors plays a vital role […]
Thunder Bay Screening of Bombardier Blood – Community Fundraiser
Bombardier Blood follows mountaineer Chris Bombardier, who lives with severe hemophilia B, as he travels to Nepal and attempts to summit Mount Everest. Filmed by hemophiliac filmmaker Patrick James Lynch, […]
What Clinical Teams Are Learning as Gene Therapies Move Into Real‑World Care
A recent discussion at the HOPA Annual Conference highlighted how hemophilia and sickle cell disease offer important lessons about the future of gene therapy access. Although both conditions qualify only […]
Ontario Opens Access Pathway for Hemophilia B Gene Therapy
Ontario has approved access to HEMGENIX, the first gene therapy for people with hemophilia B. British Columbia has also opened access, while other provinces continue their reviews. Because HEMGENIX is […]
